Hot Performing Stocks To Watch Right Now

tags:APRI,HZO,PKOH,TCPC,EXEL,DSKYF,

Source: ThinkstockNovember 17, 2017: The S&P 500 closed down 0.3% at 2,578.79. The DJIA closed down 0.4% at 23,358.21. Separately, the Nasdaq was down 0.2% at 6,782.79.

Friday was a down day for the three major U.S. exchanges after posting an incredible Thursday. Thursday's massive win was propelled by the House passing its tax bill, but it seems that wasn't enough to end Friday positively. Crude oil was positive on the day. The S&P 500 sectors were mostly negative with a few exceptions. The best performing sectors were energy and consumer discretionary, both up 0.5%. The worst performing sectors were utilities and technology, down 0.7% and 0.6%, respectively.

Crude oil was up 2.8% at $56.66.

Hot Performing Stocks To Watch Right Now: Apricus Biosciences, Inc(APRI)

Advisors' Opinion:

• [By William Romov]

  California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

• [By Chris Lange]

  Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA's review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

• [By Alexander Bird]

  Here are last week's top-performing penny stocks:

  Penny Stock Current Share Price Last Week's Gain  Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11% Nano Dimension (Nasdaq: NNDM) $2.61 75.11% Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84% CLPS Inc. (Nasdaq: CLPS) $9.72 71.15% NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33% Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98% Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82% Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70% Polymet Mining Corp. (NYSE: PLM) $1.01 31.13% Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

  Many investors struggle with finding stocks with this sort of breakout potential because they don't know where to look.

Hot Performing Stocks To Watch Right Now: MarineMax, Inc.(HZO)

Advisors' Opinion:

• [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday. Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes. Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21. MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook. Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06. Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd. Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday. Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings. PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results. Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook. Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter. Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression. O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit. BioTelemetry,
• [By Joseph Griffin]

  Get a free copy of the Zacks research report on MarineMax (HZO)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Motley Fool Transcribers]

  Marinemax Inc  (NYSE:HZO)Q1 2019 Earnings Conference CallJan. 17, 2019, 10:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Lisa Levin]

  MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.70 as the company posted upbeat Q2 results and raised its FY18 outlook.

  Equities Trading DOWN

Hot Performing Stocks To Watch Right Now: Park-Ohio Holdings Corp.(PKOH)

Advisors' Opinion:

• [By Shane Hupp]

  Shiloh Industries (NASDAQ: SHLO) and Park-Ohio (NASDAQ:PKOH) are both small-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Park-Ohio (PKOH)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Park-Ohio (NASDAQ:PKOH) announced its quarterly earnings results on Wednesday. The industrial products company reported $1.08 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.14, Fidelity Earnings reports. Park-Ohio had a return on equity of 15.41% and a net margin of 1.94%. The company had revenue of $432.20 million during the quarter, compared to analyst estimates of $397.83 million.

• [By Max Byerly]

  Park-Ohio (NASDAQ:PKOH) is set to post its quarterly earnings results before the market opens on Wednesday, May 9th. Analysts expect Park-Ohio to post earnings of $0.80 per share for the quarter.

Hot Performing Stocks To Watch Right Now: TCP Capital Corp.(TCPC)

Advisors' Opinion:

• [By Joseph Griffin]

  TCP Capital (NASDAQ:TCPC) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

• [By Motley Fool Transcribers]

  TCP Capital Corp  (NASDAQ:TCPC)Q4 2018 Earnings Conference CallFeb. 28, 2019, 1:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Lee Jackson]

  This is a solid business development company (BDC) with shares that have acted well this year. Blackrock TPC Capital Corp. (NASDAQ: TCPC) is an externally managed specialty finance company focused on middle-market lending. The company has elected to be regulated as a BDC under the Investment Company Act of 1940.

Hot Performing Stocks To Watch Right Now: Exelixis, Inc.(EXEL)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Exelixis (EXEL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  In other news, CEO Michael Morrissey sold 6,046 shares of Exelixis stock in a transaction that occurred on Wednesday, January 2nd. The shares were sold at an average price of $20.00, for a total value of $120,920.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Alan M. Garber sold 11,250 shares of Exelixis stock in a transaction that occurred on Tuesday, January 8th. The stock was sold at an average price of $23.00, for a total transaction of $258,750.00. Following the completion of the transaction, the director now directly owns 72,579 shares in the company, valued at $1,669,317. The disclosure for this sale can be found here. Insiders sold a total of 381,807 shares of company stock worth $8,003,832 in the last ninety days. Corporate insiders own 4.80% of the company’s stock.

  TRADEMARK VIOLATION WARNING: “Arizona State Retirement System Acquires 2,972 Shares of Exelixis, Inc. (EXEL)” was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright legislation. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/4126422/arizona-state-retirement-system-acquires-2972-shares-of-exelixis-inc-exel.html.

  Exelixis Profile

• [By Chris Lange]

  Exelixis Inc. (NASDAQ: EXEL) shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).

• [By Sean Williams, Chuck Saletta, and Brian Feroldi]

  With this in mind, we asked three of our Motley Fool investors to name one healthcare stock they believe could be worth buying right now. Cancer drug developer Exelixis (NASDAQ:EXEL), generic-drug manufacturer Lannett (NYSE:LCI), and medical device megacap Medtronic (NYSE:MDT) all made the cut. 

• [By George Budwell]

  Over the past few years, however, several beaten-down biotech stocks have ended up producing enormous gains for risk-tolerant investors. For example, Acadia Pharmaceuticals (NASDAQ:ACAD), Exelixis (NASDAQ:EXEL), and Dynavax Technologies Corporation (NASDAQ:DVAX) were all once so-called "penny stocks" that went on to rebound nicely once their lead clinical candidates made it successfully onto the market.

• [By Ethan Ryder]

  Exelixis (NASDAQ:EXEL) EVP Jeffrey Hessekiel sold 20,000 shares of the company’s stock in a transaction dated Friday, May 4th. The stock was sold at an average price of $22.36, for a total transaction of $447,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Hot Performing Stocks To Watch Right Now: Daiichi Sankyo Company, Limited (DSKYF)

Advisors' Opinion:

• [By ]

  Daiichi Sankyo (OTCPK:DSKYF)

  There are 4 members of the EGF receptor family, but in cancer research we tend to focus mainly on the first two: EGFR and HER2. But we are also gaining a better understanding of the third family member, HER3, which is an odd duck because of its willingness to form dimers not with itself, but with other members of the EGFR family. And it is highly active in PI3K/Akt signaling, as well. So it's no surprise that companies are trying to exploit this receptor as a therapeutic target. DSKYF's U3-1402 is an antibody-drug conjugate targeting HER3 and delivering a lethal payload to tumor cells. This phase 1/2 study focused on the use of this agent in metastatic breast cancer overexpressing HER3.